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Effects of a ~-Agonist on Muscle Protein Degradation, Enzyme Activity, and Meat
Tenderness in Steers
Tommy L.Wheeler and Mohammad Koohmaralel~
Introduction
It is generally accepted that muscle proteins are under
continual degradation during normal growth. It has been
estimated that 15 to 22% of the animal's total energy expen-
diture is for this muscle protein turnover. Regulation of the
rate of muscle protein degradation could cause dramatic
changes in rate and efficiency of muscle growth. Despite
their importance in muscle growth, the mechanisms and
control of skeletal muscle protein degradation are unknown.
It has been hypothesized that several enzyme systems are
involved at different stages of degradation, and that the cal-
pain enzyme system (which occurs naturally in muscle) may
initiate protein degradation of the muscle fiber.
It has been demonstrated that ~-agonists increase mus-
cle growth. At least a part of this growth results from
decreased protein degradation. ~-agonists also decrease
meat tenderness by increasing the activity of the calpain
inhibitor, calpastatin. We know that the calpain system has
a major role in postmortem tenderization of meat. We also
hypothesize that the calpain system plays a major role in
muscle protein degradation in the growing animal. The
objective of this study was to determine the effects of a ~-
agonist on muscle protein degradation, muscle enzyme
activity and meat tenderness of steers.
Procedure
Eight MARC III composite (1/4 Hereford, 1/4 Angus, 1/4
Pinzgauer and 1/4 Red Poll) steers weighing approximately
772 Ib were randomly assigned to control or ~-agonist fed
treatment groups. Animals were allowed unrestricted
access to a diet with or without 3 ppm of the ~-agonist
4>44969 (from Merck Sharp and Dohme) in the diet. Two
consecutive 24-hr urine collections were taken immediately
before, and at 1, 3, 5, and 6 wk after ~-agonist treatment
began. Urinary concentration of N't-methylhistidine (N'tMH)
and creatinine was measured. The skeletal muscle protein
mass of the steers was estimated from urinary creatinine
concentrations. N'tMH is a modified amino acid found only
in muscle (more than 90% in skeletal muscle) so it can be
used to measure the rate and amount of skeletal muscle
protein degradation. At the end of the 6 wk feeding period,
the steers were slaughtered according to standard humane
procedures.
Within 30 min postmortem, loin muscle samples were'
taken from the left sides for measuring the calpain enzymes
and their inhibitor, calpastatin, and the lysosomal enzymes
cathepsins Band B+L, and cystatin (cathepsin inhibitor). At
24 hr postmortem, the loin muscle from the right sides was
removed and cut into five 1-in thick steaks and vacuum
packaged. One steak each was assigned to 1, 3, 7, and 14
days postmortem aging. Loin muscle was obtained from
each shear force steak for determination of the Myofibril
Fragmentation Index (MFI), a measure of meat tenderness.
At the end of their respective aging times, the steaks
were broiled to 158°F internal temperature. The steaks
'Wheeler is a research food technologist and Koohmaraie is the
research leader, Meats Research Unit, MARC.
2'fhe authors would like to acknowledge the technical assistance of Peg
Ekeren, Sue Hauver, Kay Theer, Pat Tammen, Bob Lee, Nels Johnson
and Kathy Sorensen.
'The full report of this work will be published in the J. Anim. Sci., 1992.
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were chilled 24 hr, then .5-in diameter cores were removed
parallel to the muscle fibers for the measurement of shear
force (a mechanical measure of tenderness).
Results
The percentage of skeletal muscle protein degraded per
day, called fractional degradation rate (FOR, percentage/
day) was lower at 3 wk on trial and fractional accretion rate
(FAR, percentage/day) of skeletal muscle protein was
greater at 1, 3, 5, and 6 wk on trial compared to control
steers (Table 1). However, fractional synthesis rate (FSR,
percentage/day) was not different between treatment
groups. FAR = FSR + FOR. Several researchers have
shown a decrease in FOR as a result of ~-agonist feeding,
while others have inferred a reduction in FOR from a failure
to find a change in FSR when accretion increased.
A convincing body of literature indicates that the calpain
enzyme system has a major role in postmortem tenderiza-
tion of meat. It also has been hypothesized that the cal-
pains initiate muscle protein turnover by releasing myofila-
ments from the muscle fiber surface. Because ~-agonists
increase muscle growth, and reduce postmortem tenderiza-
tion, it was of interest to determine the effects on the calpain
enzyme system of feeding ~-agonist. At 0 hr (30 min post-
mortem), ~-calpain and m-calpain activities were not differ-
ent, but calpastatin activity was increased 60.0% in loin
muscle from ~-agonist fed steers (Table 2). After 7 days of
storage at 35°F, ~-calpain and calpastatin activities had
decreased relative to 0 hr, but again, only calpastatin was
changed due to feeding the ~-agonist (348% increase).
These data on ~-calpain and calpastatin are consistent with
previous findings.
Although not involved in postmortem tenderization, lyso-
somal cathepsins are hypothesized to be involved in protein
turnover. However, there were no significant differences in
cathepsin B, cathepsins B+L, or cystatin activities between
control and ~-agonist fed steers at 0 hr or 7 day postmortem
(Table 2).There was a decrease in cathepsins Band B+L
activities measured at 7 days compared to 0 hr postmortem.
Previous data indicate very inconsistent effects of ~-ago-
nists on cathepsin activities, implying they are not involved
in the rate limiting step of muscle protein degradation.
Consistent with the role of the calpain enzyme system in
postmortem tenderization, tenderness was dramatically
reduced in the loin muscle from ~-agonist fed steers (Fig. 1).
Shear force values decreased from 1 to 7 day postmortem in
control steers. However, shear force of ~-agonist fed steers
did not vary from 1 to 14 day postmortem. In addition, MFI
did not change in muscle from ~-agonist fed steers from 1 to
14 day postmortem, although MFI increased from 1 to 7 day
postmortem in control steers. The inhibition of calpain activ-
ity by the high calpastatin activity in the treated steers com-
pletely blocked normal postmortem tenderization.
The mechanisms responsible for the increased muscle
growth are still very much in question. Increased synthesis,
decreased degradation, or both, have been reported as a
result of ~-agonist feeding. Our results indicate fractional
degradation rates (FOR) in treated steers had begun to
decline after 1 wk, became significantly lower at 3 wk, but
were again similar to controls by 6 wk of ~-agonist feeding.
These results are consistent with previous reports indicating
the effects of ~-agonists on protein degradation are rapid,
and then decline. Other researchers have stated that ~-
agonists induce a short-term decrease in degradation and
that as degradation returns to normal, protein synthesis
increases. Estimated FSR was not different between con-
trol and treated steers. However, FSR was numerically
higher at 5 and 6 wk. Thus, our data tend to support a
diphasic effect of ~-agonist on protein turnover.
Considering the different ~-agonists, species to which they
are administered, varying dosages and time frames, and
methodologies and time courses for measuring FSR and
FOR, it is unlikely that all discrepancies will ever be com-
pletely reconciled. However, based on our data and a
broad interpretation of previous data (to account for varying
experimental conditions), it seems likely that ~-agonists
exert their effect on muscle growth through both decreased
degradation and increased synthesis of skeletal muscle pro-
teins. This is in contrast to increased growth of normal,
rapidly growing muscle in which both synthesis and degra-
dation are increased, although the former to a greater
extent.
The role of various muscle enzymes in muscle protein
turnover has not been determined. However, the calpain
proteolytic system has been implicated in the initial, and
possibly rate limiting, steps of muscle protein degradation.
Furthermore, it has been clearly demonstrated that the cal-
pain enzyme system is largely responsible for the observed
variation in postmortem meat tenderness. Thus, it is
believed that the calpain system could regulate muscle pro-
tein degradation during both muscle growth and post-
mortem storage of meat. In support of this hypothesis, it
has been consistently demonstrated that ~-agonist feeding
increases muscle calpastatin activity, thereby reducing post-
mortem proteolysis by calpain and meat tenderness.
Because postmortem proteolysis by calpain is reduced, it is
conceivable that calpain proteolysis in vivo also might be
reduced, thereby reducing the rate of muscle protein degra-
dation (if calpain were involved in a rate limiting step). Our
data are consistent with the previously reported increase in
calpastatin activity and reduced meat tenderness resulting
from ~-agonist feeding. The combined observationsof
decreased calpain proteolytic capacity and reduced FOR in
~-agonist fed steers compared to control animals supports
this hypothesis. A greater understanding of the in vivo reg-
ulation of the calpain system is needed to further evaluate
this hypothesis.
Table 1-Effects of l3-agonlst on skeletal muscle protein turnover of growing steers
a Fractional degradation rate 01skeletal muscle protein.
b Fractional accretion rate 01skeletal muscle protein.
e Fractional synthesis rate 01skeletal muscle protein. FSR-FDR+FAR
* Treatment differences within week were signilicant at (P < .05).
Table 2-Effects of l3-agonlst feeding and time postmortem on muscle enzyme activities In loin muscle
a Low calcium requiring calpain.
b High calcium requiring calpain.
e Total activity.
d Measured as the ratio 01B+l activity alter to belore cystatin(s) removal.
" 3 pprn 01fl-agonist lor 6 wk.
* Treatment differences within postmortem time were significant (P < .05).
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Owk 1wk 3wk 5wk 6wk
-
Control Treated Control Treated Control Treated Control Treated Control Treated
FORa, %/day 1.13 1.14 1.24 1.09 2.25 1.77* 1.81 1.77 1.41 1.56
FARb,%/day .48 .63* .32 .50* .27 .45* .12 .36*
FSRe, %/day 1.72 1.72 2.57 2.27 2.08 2.22 1.53 1.92
Cathepsin Cathepsins
I1-Calpaina m-Calpaina Calpastatinb Be B+Le Cystatind
Control
o day 1.05 1.44 3.72 46.0 235.5 3.9
7 day .02 1.27 .69 33.8 193.5 4.5
Treated"
o day 1.15 1.51 5.95* 36.5 215.5 4.3
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Figure 1 - The effects of feeding 3 ppm of ~-agonist to growing steers for 6 wk on (A) shear force and (B) Myofibril Fragmentation Index dur-
ing postmortem storage at 35°F.
. Treatment differences withinpostmortemtime were significant(P < .05).
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